Fighting cancer is no easy task. This disease is very diverse as well as very dangerous. The medications that are used for fighting this disease takes time to be developed. There is a ton of research that goes into producing such powerful medications and getting the medication approved by the FDA can be frustrating. Dr. Clay Siegall is one of many people that has gotten a drug approved by the FDA, and this drug has gone on to help people all around the world. ADCETRIS is one of the very best cancer-fighting drugs to date. Also referred to as Brentuximab Vedotin, ADCETRIS is leading the charge of modern-day targeted-cancer therapies. In an overall sense, this drug has brought in more than $350 million in revenue for Seattle Genetics.
Dr. Clay Siegall plays an important role at Seattle Genetics in more ways than one. He is the heart and soul of this innovative high-tech company. In other words, Dr. Siegall is the company’s founder as well as its president. Science and innovation goes hand-to-hand here. Dr. Siegall is a firm believer of mixing technology with medicine. The results of this eclectic combination is phenomenal. ADCETRIS is being used in more than 60 different countries across the globe, and it has helped Seattle Genetics’ stock more than double in a span of a few years. By expanding its pipeline, this company is performing clinical trials in medicine for Hodgkin Lymphoma, for Non-Hodgkin Lymphoma, for breast cancer and for urothelial cancer.
Who else can do it any better? Dr. Siegall is a mastermind, and he gets things done on a consistent basis because time is of the essence. This celebrated and well-accomplished doctor has found a recipe for success, and he’s using this recipe to save lives. Dr. Clay Siegall and Seattle Genetics is surely a winning solution.